Myelodysplastic syndromes (MDS) are heterogeneous group of clonal hematological
neoplasms characterized by cytopenias, sighs of dysplasia and high risk of transformation in …

Background. Myelodysplastic syndromes (MDS) are a heterogeneous group of clonal
diseases of the hematopoiesis system characterized by dismyelopoiesis and cytopenia, the …

Introduction: Myelodysplastic syndrome (MDS) comprises a heterogeneous group of clonal
hematopoietic stem cell diseases with variable clinical course and risk of evolution to acute …

Background Myelodysplastic syndromes (MDS) can present a challenge for clinicians.
Multicolor flow cytometry (MFC) can aid in establishing a diagnosis. The aim of this study …

Multiparameter flow cytometry (MFC) is one of the essential ancillary methods in bone
marrow (BM) investigation of patients with cytopenia and suspected myelodysplastic …

Abstract 4846 Myelodysplastic syndrome (MDS) is heterogeneous clonal hematopoietic
stem cell disorder characterized by cytopenia (s) and dysplasia in one or more cell lineage …

Background: Myelodysplastic syndrome (MDS) is a term used to encompass a spectrum of
clonal (neoplastic) myeloid disorders The combination of obvious marrow dysplasia and …

Myelodysplastic syndromes (MDSs) are clonal disorders of hematopoiesis that exhibit
heterogeneous clinical presentation and morphological findings, which complicates …

Multiparameter flow cytometry (MFC) shows promise in the diagnosis and differential
diagnosis of myelodysplastic neoplasms (MDS). By identifying abnormal …

Myelodysplastic syndromes (MDS) constitute a heterogeneous group of hematopoietic stem
cell disorders, characterized by ineffective hematopoiesis resulting in cytopenias and a …